# PTC Therapeutics, Inc.: Form 8-K, filed Jan 3, 2025

- Company: [PTC Therapeutics, Inc.](/companies/ptct.md) (CIK 1070081)
- Form: 8-K
- Filed: 2025-01-03
- Accepted by EDGAR: Jan 3, 2025, 16:27 ET
- Period: 2024-12-31
- Accession: 0001070081-25-000004
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1070081/000107008125000004/tmb-20241231x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1070081/000107008125000004/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1070081/000107008125000004/tmb-20241231x8k.htm

Filed Jan 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001070081-25-000004. Last ingested by Listed: Nov 3, 2026, 09:26 ET. No prices; not investment advice.